{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:19:57Z","timestamp":1792153197804,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neuro.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:23:17Z","timestamp":1738336997000},"page":"37-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Therapeutic potential of pranlukast against cuprizone-induced inflammatory demyelination and sensory impairment in mice: Comparison with fingolimod"],"prefix":"10.1016","volume":"107","author":[{"given":"Greice","family":"Nascimento Pires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Pereira Laurindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Dos Santos Heringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanny","family":"Calixto da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora","family":"Magalh\u00e3es Portela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"de P\u00e1dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz","family":"Miranda De S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saulo Augusto","family":"Alves Da Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Esp\u00edrito Santo Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Blanco Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Batista Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Rocha Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2025.01.004_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2015.06.006","article-title":"Fingolimod does not enhance cerebellar remyelination in the cuprizone model","volume":"v. 285","author":"Alme","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuro.2025.01.004_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fncel.2020.00043","article-title":"CD8 T-cell recruitment into the central nervous system of cuprizone-fed mice: relevance to modeling the etiology of multiple sclerosis","volume":"14","author":"Almuslehi","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuro.2025.01.004_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12974-017-0936-0","article-title":"Inflammatory demyelination alters subcortical visual circuits","volume":"v. 14","author":"Ara\u00fajo","year":"2017","journal-title":"J. Neuroinflamm."},{"issue":"n. 10","key":"10.1016\/j.neuro.2025.01.004_bib4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/glia.20519","article-title":"NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells","volume":"v. 55","author":"Baracskay","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neuro.2025.01.004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.03.020","article-title":"Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice","volume":"v. 320","author":"B\u00f6lcskei","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"n. 1\u20132","key":"10.1016\/j.neuro.2025.01.004_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neurol.2019.02.007","article-title":"Mechanism of action of s1p receptor modulators in multiple sclerosis: the double requirement","volume":"v. 176","author":"Bordet","year":"2020","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.neuro.2025.01.004_bib7","first-page":"102","article-title":"Computational screening of biomarkers and potential drugs for arthrofibrosis based on combination of sequencing and large nature language model","volume":"44","author":"Chen","year":"2024","journal-title":"J. Orthop. Transl."},{"issue":"n. 11","key":"10.1016\/j.neuro.2025.01.004_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007754","article-title":"What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach","volume":"v. 4","author":"Chomiak","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuro.2025.01.004_bib9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"v. 372","author":"Compston","year":"2008","journal-title":"Lancet"},{"issue":"n. 3","key":"10.1016\/j.neuro.2025.01.004_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1474-4422(10)70007-7","article-title":"Combination therapy in multiple sclerosis","volume":"v. 9","author":"Conway","year":"2010","journal-title":"Lancet Neurol."},{"issue":"n. 4","key":"10.1016\/j.neuro.2025.01.004_bib11","first-page":"1025","article-title":"Treatment of Multiple Sclerosis","volume":"v. 28","author":"Cross","year":"2022","journal-title":"CONTINUUM: Lifelong Learn. Neurol."},{"key":"10.1016\/j.neuro.2025.01.004_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.brainres.2014.12.004","article-title":"Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis","volume":"v. 13","author":"Di Filippo","year":"2015","journal-title":"Brain Res."},{"issue":"n. 5","key":"10.1016\/j.neuro.2025.01.004_bib13","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/ijms21051852","article-title":"The GPR17 receptor: a promising goal for therapy and a potential marker of the neurodegenerative process in multiple sclerosis","volume":"v. 21","author":"Dziedzic","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"n. 6","key":"10.1016\/j.neuro.2025.01.004_bib14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/glia.23971","article-title":"Astrocytes as a target for Nogo-A and implications for synapse formation in vitro and in a model of acute demyelination","volume":"v. 69","author":"Esp\u00edrito-Santo","year":"2021","journal-title":"Glia"},{"issue":"n. 1","key":"10.1016\/j.neuro.2025.01.004_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/1673-5374.340407","article-title":"Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?","volume":"v. 18","author":"Esp\u00edrito-Santo","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"n. 12","key":"10.1016\/j.neuro.2025.01.004_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin \u2014 from mechanisms to experimental medicines","volume":"v. 18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuro.2025.01.004_bib17","doi-asserted-by":"crossref","first-page":"7314","DOI":"10.1080\/21655979.2021.1979352","article-title":"Knockdown of G protein-coupled receptor-17 (GPR17) facilitates the regeneration and repair of myelin sheath post-periventricular leukomalacia (PVL)","volume":"12","author":"He","year":"2021","journal-title":"Bioengineered"},{"issue":"n. 3","key":"10.1016\/j.neuro.2025.01.004_bib18","doi-asserted-by":"crossref","DOI":"10.1042\/AN20090032","article-title":"Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination","volume":"v.1","author":"Hibbits","year":"2009","journal-title":"Asn Neuro"},{"issue":"n. 3","key":"10.1016\/j.neuro.2025.01.004_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/nan.12373","article-title":"Sudan black: a fast, easy and non-toxic method to assess myelin repair in demyelinating diseases","volume":"v. 43","author":"Ineichen","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuro.2025.01.004_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fncel.2020.00239","article-title":"The CNS myelin proteome: deep profile and persistence after post-mortem delay","volume":"14","author":"Jahn","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"n. 4","key":"10.1016\/j.neuro.2025.01.004_bib21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/glia.23937","article-title":"Cuprizone-induced demyelination triggers a CD8-pronounced T cell recruitment","volume":"v. 69","author":"Kaddatz","year":"2021","journal-title":"Glia"},{"issue":"n. 3","key":"10.1016\/j.neuro.2025.01.004_bib22","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0004-16.2016","article-title":"Microglial contact prevents excess depolarization and rescues neurons from excitotoxicity","volume":"v. 3","author":"Kato","year":"2016","journal-title":"eNeuro"},{"issue":"n. 2","key":"10.1016\/j.neuro.2025.01.004_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"v. 91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"issue":"n. 3","key":"10.1016\/j.neuro.2025.01.004_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/glia.23272","article-title":"Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination","volume":"v. 66","author":"Kim","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.neuro.2025.01.004_bib25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1352458512438723","article-title":"FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination","volume":"v.18","author":"Kipp","year":"2012","journal-title":"Mult. Scler."},{"issue":"n. 5","key":"10.1016\/j.neuro.2025.01.004_bib26","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1007\/s00415-021-10956-1","article-title":"Neurological update: treatment escalation in multiple sclerosis patients refractory to fingolimod-potentials and risks of subsequent highly active agents","volume":"v. 269","author":"Korsen","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuro.2025.01.004_bib27","doi-asserted-by":"crossref","DOI":"10.2174\/0118715273328174241007060331","article-title":"BBBper: a machine learning-based online tool for blood-brain barrier (BBB) permeability prediction","author":"Kumar","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"n. 9","key":"10.1016\/j.neuro.2025.01.004_bib28","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1046\/j.1460-9568.1998.00283.x","article-title":"Expression of the mRNA for the \u03b22 subunit of the voltage-dependent sodium channel in rat CNS","volume":"v. 10","author":"Levy-Mozziconacci","year":"1998","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.neuro.2025.01.004_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax2518","article-title":"Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs","volume":"5","author":"Luginina","year":"2019","journal-title":"Sci. Adv."},{"issue":"n. 5","key":"10.1016\/j.neuro.2025.01.004_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.physbeh.2009.09.005","article-title":"A revised Racine's scale for PTZ-induced seizures in rats","volume":"v. 98","author":"L\u00fcttjohann","year":"2009","journal-title":"Physiol. Behav."},{"issue":"n. 12","key":"10.1016\/j.neuro.2025.01.004_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneurol.2015.222","article-title":"Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis","volume":"v. 11","author":"Mandolesi","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"n. 1","key":"10.1016\/j.neuro.2025.01.004_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"v. 11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuro.2025.01.004_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2018.07.018","article-title":"Lack of Galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice","volume":"v. 1700","author":"Mendon\u00e7a","year":"2018","journal-title":"Brain Res."},{"issue":"n. 9","key":"10.1016\/j.neuro.2025.01.004_bib34","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"v. 16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"n. 1","key":"10.1016\/j.neuro.2025.01.004_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2010.04.001","article-title":"Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice","volume":"v. 39","author":"Mirrione","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"n. 4","key":"10.1016\/j.neuro.2025.01.004_bib36","first-page":"330","article-title":"The effect of Zingiber officinale extract on preventing demyelination of corpus callosum in a rat model of multiple sclerosis","volume":"v. 26","author":"Moradi","year":"2022","journal-title":"Iran. Biomed. J."},{"issue":"n. 1","key":"10.1016\/j.neuro.2025.01.004_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1523\/JNEUROSCI.0849-14.2015","article-title":"Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration","volume":"v. 35","author":"Moyon","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2025.01.004_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrn2797","article-title":"Myelination and the trophic support of long axons","volume":"v. 11","author":"Nave","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"n. 3","key":"10.1016\/j.neuro.2025.01.004_bib39","first-page":"242","article-title":"Pharmacodynamic properties of leukotriene receptor antagonists","volume":"v. 54","author":"Nicosia","year":"1999","journal-title":"Monaldi Arch. chest Dis. =\u2009Arch. Monaldi per Le. Mal. Del. Torace"},{"issue":"n. 5726","key":"10.1016\/j.neuro.2025.01.004_bib40","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"v. 308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuro.2025.01.004_bib41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neures.2018.08.013","article-title":"Axonal and neuronal degeneration in myelin diseases","volume":"v. 139","author":"Ohno","year":"2019","journal-title":"Neurosci. Res."},{"issue":"n. 2\u20133","key":"10.1016\/j.neuro.2025.01.004_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12017-017-8442-1","article-title":"Models for Studying Myelination, Demyelination and Remyelination","volume":"v. 19","author":"Osorio-Querejeta","year":"2017","journal-title":"NeuroMol. Med."},{"issue":"n. 41","key":"10.1016\/j.neuro.2025.01.004_bib43","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1523\/JNEUROSCI.0898-16.2016","article-title":"Olig2-targeted G-protein-coupled receptor Gpr17 regulates oligodendrocyte survival in response to lysolecithin-induced demyelination","volume":"v. 36","author":"Ou","year":"2016","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuro.2025.01.004_bib44","series-title":"The mouse brain in stereotaxic coordinates: hard cover edition","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuro.2025.01.004_bib45","article-title":"P\u00edo del R\u00edo Hortega and the discovery of the oligodendrocytes","volume":"v. 9","author":"P\u00e9rez-Cerd\u00e1","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuro.2025.01.004_bib46","first-page":"1811","article-title":"Comparison of morphological and functional outcomes of mouse sciatic nerve repair with three biodegradable polymer conduits containing poly(lactic acid). Neural Regeneration","volume":"v. 13","author":"Pestana","year":"2018","journal-title":"Research"},{"issue":"n. 4","key":"10.1016\/j.neuro.2025.01.004_bib47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/cells9040812","article-title":"Myelin fat facts: an overview of lipids and fatty acid metabolism","volume":"v. 9","author":"Poitelon","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.neuro.2025.01.004_bib48","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1161\/STROKEAHA.117.018505","article-title":"Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway","volume":"48","author":"Qin","year":"2017","journal-title":"Stroke"},{"issue":"n. 5","key":"10.1016\/j.neuro.2025.01.004_bib49","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","article-title":"Neuroinflammation and synaptic loss","volume":"v. 37","author":"Rao","year":"2012","journal-title":"Neurochem. Res."},{"issue":"n. 10","key":"10.1016\/j.neuro.2025.01.004_bib50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrneurol.2009.139","article-title":"Predicting responders to therapies for multiple sclerosis","volume":"v. 5","author":"Rio","year":"2009","journal-title":"Nat. Rev. Neurol."},{"issue":"n. 6","key":"10.1016\/j.neuro.2025.01.004_bib51","first-page":"28","article-title":"Disease-modifying therapies in multiple sclerosis: overview and treatment considerations. Federal Practitioner: For the Health Care Professionals of the VA","volume":"v. 33","author":"Robertson","year":"2016","journal-title":"DoD., PHS"},{"issue":"1","key":"10.1016\/j.neuro.2025.01.004_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11064-014-1478-9","article-title":"Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats","volume":"40","author":"Saad","year":"2015","journal-title":"Neurochem. Res."},{"issue":"n. 7","key":"10.1016\/j.neuro.2025.01.004_bib53","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/glia.24148","article-title":"The roles of microglia and astrocytes in phagocytosis and myelination: insights from the cuprizone model of multiple sclerosis","volume":"v. 70","author":"Sen","year":"2022","journal-title":"Glia"},{"issue":"n. 11","key":"10.1016\/j.neuro.2025.01.004_bib54","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/cells8111314","article-title":"Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis","volume":"v. 8","author":"Sen","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuro.2025.01.004_bib55","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbi.2020.01.021","article-title":"Behavioural and histological changes in cuprizone-fed mice","volume":"v. 87","author":"Sen","year":"2020","journal-title":"Brain, Behav., Immun."},{"issue":"n. 3","key":"10.1016\/j.neuro.2025.01.004_bib56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.braindev.2012.04.001","article-title":"Open study of pranlukast add-on therapy in intractable partial epilepsy","volume":"v. 35","author":"Takahashi","year":"2013","journal-title":"Brain Dev."},{"issue":"4","key":"10.1016\/j.neuro.2025.01.004_bib57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1017\/S1461145713001314","article-title":"Protective effect of pranlukast on A\u03b2\u2081\u208b\u2084\u2082-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1","volume":"17","author":"Tang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"n. 2","key":"10.1016\/j.neuro.2025.01.004_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jphs.2018.01.001","article-title":"LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model","volume":"v. 136","author":"Tsukahara","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"n. 7","key":"10.1016\/j.neuro.2025.01.004_bib59","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1007\/s12035-015-9404-y","article-title":"The effect of melatonin on behavioral, molecular, and histopathological changes in cuprizone model of demyelination","volume":"v. 53","author":"Vakilzadeh","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuro.2025.01.004_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2019.02.029","article-title":"PTZ-induced seizures in mice require a revised Racine scale","volume":"v. 95","author":"Van Erum","year":"2019","journal-title":"Epilepsy Behav.: EB"},{"issue":"n. 14","key":"10.1016\/j.neuro.2025.01.004_bib61","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"v. 26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neuro.2025.01.004_bib62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","article-title":"Brain-spleen axis in health and diseases: A review and future perspective","volume":"v. 182","author":"Wei","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"n. 8","key":"10.1016\/j.neuro.2025.01.004_bib63","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/jnr.23997","article-title":"Ultrastructural abnormalities and loss of myelinated fibers in the corpus callosum of demyelinated mice induced by cuprizone","volume":"v. 95","author":"Xiu","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuro.2025.01.004_bib64","article-title":"Therapeutic advances in multiple sclerosis","volume":"v. 13","author":"Yang","year":"2022","journal-title":"Front. Neurol."},{"issue":"n. 4","key":"10.1016\/j.neuro.2025.01.004_bib65","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/bcp.14198","article-title":"The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: a meta-analysis","volume":"v. 86","author":"Yang","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"n. 7745","key":"10.1016\/j.neuro.2025.01.004_bib66","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of oligodendrocyte generation in multiple sclerosis","volume":"v. 566","author":"Yeung","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2025.01.004_bib67","first-page":"1","article-title":"Modulating inflammation and neuroprotection in multiple sclerosis","volume":"v. 00","author":"Yong","year":"2017","journal-title":"J. Neurol. Res."},{"key":"10.1016\/j.neuro.2025.01.004_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2014.05.026","article-title":"Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1","volume":"1572","author":"Zhang","year":"2014","journal-title":"Brain Res."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X25000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X25000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T21:23:20Z","timestamp":1741728200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X25000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":68,"alternative-id":["S0161813X25000130"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2025.01.004","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of pranlukast against cuprizone-induced inflammatory demyelination and sensory impairment in mice: Comparison with fingolimod","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}